Viropro Stock Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Viropro are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Viropro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Viropro is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Last Split Factor 1:12.14 | Last Split Date 2003-11-26 |
Viropro Relative Risk vs. Return Landscape
If you would invest 0.00 in Viropro on November 9, 2025 and sell it today you would earn a total of 0.00 from holding Viropro or generate 0.0% return on investment over 90 days. Viropro is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Viropro, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Viropro Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Viropro for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Viropro can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Viropro generated a negative expected return over the last 90 days | |
| Viropro has some characteristics of a very speculative penny stock | |
| Viropro has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 571.1 K. Net Loss for the year was (1.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Viropro currently holds about 119.25 K in cash with (675.62 K) of positive cash flow from operations. | |
| Viropro has a very weak financial position based on the latest SEC disclosures |
Viropro Fundamentals Growth
Viropro Stock prices reflect investors' perceptions of the future prospects and financial health of Viropro, and Viropro fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Viropro Stock performance.
| Operating Margin | (2.09) % | ||||
| Current Valuation | 11.91 M | ||||
| Shares Outstanding | 916.09 M | ||||
| Price To Earning | 0.10 X | ||||
| Price To Book | 1.17 X | ||||
| Price To Sales | 18.15 X | ||||
| Revenue | 571.1 K | ||||
| Net Income | (1.01 M) | ||||
| Cash And Equivalents | 119.25 K | ||||
| Total Debt | 175.56 K | ||||
| Debt To Equity | 0.57 % | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | (675.62 K) | ||||
| Market Capitalization | 18.32 K | ||||
| Total Asset | 2.11 M | ||||
| Retained Earnings | (17 M) | ||||
| Working Capital | (2.87 M) | ||||
| Current Asset | 291 K | ||||
| Current Liabilities | 3.16 M | ||||
About Viropro Performance
By examining Viropro's fundamental ratios, stakeholders can obtain critical insights into Viropro's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Viropro is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (3.85) | (4.04) | |
| Return On Capital Employed | (0.62) | (0.58) | |
| Return On Assets | (0.43) | (0.45) | |
| Return On Equity | (0.62) | (0.66) |
Things to note about Viropro performance evaluation
Checking the ongoing alerts about Viropro for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Viropro help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Viropro generated a negative expected return over the last 90 days | |
| Viropro has some characteristics of a very speculative penny stock | |
| Viropro has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 571.1 K. Net Loss for the year was (1.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Viropro currently holds about 119.25 K in cash with (675.62 K) of positive cash flow from operations. | |
| Viropro has a very weak financial position based on the latest SEC disclosures |
- Analyzing Viropro's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Viropro's stock is overvalued or undervalued compared to its peers.
- Examining Viropro's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Viropro's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Viropro's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Viropro's stock. These opinions can provide insight into Viropro's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viropro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Will Biotechnology sector continue expanding? Could Viropro diversify its offerings? Factors like these will boost the valuation of Viropro. If investors know Viropro will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Viropro data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Revenue Growth 1.19 |
Understanding Viropro requires distinguishing between market price and book value, where the latter reflects Viropro's accounting equity. The concept of intrinsic value - what Viropro's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Viropro's price substantially above or below its fundamental value.
Please note, there is a significant difference between Viropro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viropro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Viropro's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.